ESMO 2026 - INSPIRE-LM: A New Approach with Dr. Kamran Ahmed

Addressing an urgent unmet need in HER2-positive breast cancer, Dr. Kamran Ahmed presents INSPIRE-LM, a phase II trial exploring radiation followed by intrathecal trastuzumab and pertuzumab for leptomeningeal metastases.